Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
US Army
Argus Health
QuintilesIMS
Moodys
Julphar
McKesson
Citi
Baxter
Chinese Patent Office

Generated: February 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076405

« Back to Dashboard

NDA 076405 describes TRI-LEGEST 21, which is a drug marketed by Barr and is included in one NDA. Additional details are available on the TRI-LEGEST 21 profile page.

The generic ingredient in TRI-LEGEST 21 is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
Summary for 076405
Tradename:TRI-LEGEST 21
Applicant:Barr
Ingredient:ethinyl estradiol; norethindrone acetate
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORAL-21Strength0.02MG,0.03MG,0.035MG;1MG,1MG,1MG
Approval Date:Oct 26, 2007TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
US Army
AstraZeneca
Julphar
Johnson and Johnson
Medtronic
Federal Trade Commission
Moodys
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot